Measuring Emissions as Part of a Regulatory Regime. Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4

Size: px
Start display at page:

Download "Measuring Emissions as Part of a Regulatory Regime. Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4"

Transcription

1 Measuring Emissions as Part of a Regulatory Regime Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4

2 . (b) a list of all ingredients contained in, and emissions resulting from the use of, the product, by brand name and type, including quantities thereof; (c) toxicological data regarding the product's ingredients and emissions, including when heated, referring in particular to their effects on the health of consumers when inhaled and taking into account, inter alia, any addictive effect;

3 Annex notification requirements Emissions: it is required that the methods for testing be described, but there is no information on which emissions they want data.

4 Room for interpretation.

5 Room for interpretation.

6 Room for interpretation.

7 CEN/TC 437 Setting quality and safety standards CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine

8 CEN/TC 437/WG 4 Requirements and test methods for emissions Workplan priorities: CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment (e.g. puffing parameters, aerosol generation and collection, laboratory environmental conditions) Liaison with ISO/TC 126/SC 3/WG 2 CORESTA CRM 81 AFNOR XP D Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine

9 CEN/TC 437/WG 4 Requirements and test methods for emissions Workplan priorities: Reference products CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Reference liquid (e.g. ingredients characteristics, storage conditions) BSI/PAS 54115:2015 AFNOR XP D AEMSA e-liquid manufacturing standards Specific reference liquids for analytical methods validation Reference device (e.g. technical parameters, design) BSI/PAS 54115:2015 AFNOR XP D US document Consistent delivery of nicotine

10 CEN/TC 437/WG 4 Requirements and test methods for emissions CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine Workplan priorities: Measurements/quantification/q ualification of emissions Constituent to be measured in the emissions: Nicotine Carbonyls Metals TPD draft data dictionary for e-cig MHRA document BSI/PAS 54115:2015 AFNOR XP D FDA guidance

11 CEN/TC 437/WG 4 Requirements and test methods for emissions CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine Workplan priorities: Measurements/quantification/q ualification of emissions Analytical methods for constituents to be measured in the emissions: availability of analytical methods applicability of analytical methods ICH Guidance Q2 British Pharmacopoeia (BP) European Pharmacopoeia (Ph Eur) US Pharmacopeia-National Formulary Japonese Pharmacopoeia (JP) development or modification of test methods, if required expression of the results validation

12 CEN/TC 437/WG 4 Requirements and test methods for emissions Workplan priorities: CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine Consistent delivery of nicotine (e.g. parameters and definitions) CHMP guidance: Pharmaceutical quality of inhalation and nasal products ICH Guidance Q2 (R1): Validation of analytical procedures: text and methodology EU pharmacopoeia - Ph Eur monograph (Uniformity of Dosage Units) AFNOR XP D

13 CEN/TC 437/WG 4 Requirements and test methods for emissions Challenges & Concerns Need for substantial coordination Growing complexity (likely WI proliferation) Loss of human resources (increasing no-show) Can we meet the deadline?

E-Cigarette Product Regulation and Standardisation

E-Cigarette Product Regulation and Standardisation E-Cigarette Product Regulation and Standardisation Derek Mariner British American Tobacco, Research & Development, Southampton UK E-cigarette Workshop, Paper STW03 CORESTA Smoke Science and Product Technology

More information

Contribution To Standards Development For Next Generation Products. Eduardo BEREA Alternative Ingredients ENDS 2018 London 4-5 June 2018

Contribution To Standards Development For Next Generation Products. Eduardo BEREA Alternative Ingredients ENDS 2018 London 4-5 June 2018 Contribution To Standards Development For Next Generation Products Eduardo BEREA Alternative Ingredients ENDS 2018 London 4-5 June 2018 2010s Disposables / Cigalikes Rechargeable Cigalike & Cartomizers

More information

Contribution To Standards Development For Next Generation Products. Dr Nils ROSE

Contribution To Standards Development For Next Generation Products. Dr Nils ROSE Contribution To Standards Development For Next Generation Products Dr Nils ROSE 2010s Disposables / Cigalikes Rechargeable Cigalike & Cartomizers Fixed Voltage Devices Drip Tips Open System Atomizer Single

More information

Pierre-Marie GUITTON Next Generation Nicotine Delivery London June, 2017

Pierre-Marie GUITTON Next Generation Nicotine Delivery London June, 2017 Contribution To Develop Standards For The Global Vapour Industry Pierre-Marie GUITTON Next Generation Nicotine Delivery London - 14-15 June, 2017 Outline Introduction to CORESTA CORESTA activities Process

More information

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1) INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

E-Vapour (EVAP) Sub-Group 2017 Report. Kitzbühel, Austria October 10, 2017

E-Vapour (EVAP) Sub-Group 2017 Report. Kitzbühel, Austria October 10, 2017 E-Vapour (EVAP) Sub-Group 2017 Report Kitzbühel, Austria October 10, 2017 History Evolution o 2014, formation of E-cigarette TF o 2016, TF activities completed; formation of E-vapor product SG 2 E-Vapour

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

Smoking Behaviour Sub-Group (TSB)

Smoking Behaviour Sub-Group (TSB) Smoking Behaviour Sub-Group (TSB) 2016 Annual Report Coordinator: Secretary: SC Liaison: Dr Krishna Prasad (BAT) Dr Xavier Cahours (ITG) Dr Martin Blumenstock (BAT) 11 October 2016 Berlin, Germany TSB

More information

Applicant Name: GD Sigelei Electroinc Tech Co., Ltd B7 Building, No.1 District, Xicheng Science and Technology Park, Hengli Town, Dongguan, China

Applicant Name: GD Sigelei Electroinc Tech Co., Ltd B7 Building, No.1 District, Xicheng Science and Technology Park, Hengli Town, Dongguan, China Date: Jan.17, 2018 Applicant Name: GD Sigelei Electroinc Tech Co., Ltd Applicant Add.: B7 Building, No.1 District, Xicheng Science and Technology Park, Hengli Town, Dongguan, China Test sample(s) was(were)

More information

Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery

Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery Global Nicotine Forum 2018 Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery Ed Stephens University of St Andrews Declaration: No conflicts of interest

More information

ONLINE AEROSOL ANALYSIS USING FTIR: ASSESSING CARBONYL YIELDS IN E-CIGARETTE AEROSOL

ONLINE AEROSOL ANALYSIS USING FTIR: ASSESSING CARBONYL YIELDS IN E-CIGARETTE AEROSOL ONLINE AEROSOL ANALYSIS USING FTIR: ASSESSING CARBONYL YIELDS IN E-CIGARETTE AEROSOL 27.Aug- 1.Sep 217 European Aerosol Conference 217 Zürich, Switzerland Falk Radtke PMI R&D, Philip Morris Products S.A.,

More information

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use Frequently Asked Questions Q4B: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions The Q4B Expert Working Group developed a set of frequently asked questions to help users

More information

Cooperation Centre for Scientific Research Relative to Tobacco. CORESTA Guide N 22

Cooperation Centre for Scientific Research Relative to Tobacco. CORESTA Guide N 22 Cooperation Centre for Scientific Research Relative to Tobacco CORESTA Guide N 22 Technical Guide for the Selection of Appropriate Intense Vaping Regimes for E-Vapour Devices February 2018 E-Vapour Sub-Group

More information

Sub-components in Nicotine cessation products?

Sub-components in Nicotine cessation products? Sub-components in Nicotine cessation products? Mr Arun Sarda, Director of Quality and Regulatory Affairs Member of the HEITKAMP & THUMANN GROUP Regulatory approval of sub-components in nicotine cessation

More information

Work plan for the joint CHMP/ CVMP Quality Working Party (QWP) for 2018

Work plan for the joint CHMP/ CVMP Quality Working Party (QWP) for 2018 4 December 2017 EMA/CHMP/CVMP/QWP/504882/2017 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Work plan for the joint CHMP/ CVMP Quality

More information

TOBACCO PRODUCT OR MEDICAL PRODUCT?

TOBACCO PRODUCT OR MEDICAL PRODUCT? TOBACCO PRODUCT OR MEDICAL PRODUCT? Priscilla Callahan-Lyon, MD Deputy Director Division of Individual Health Science Office of Science, CTP Grail Sipes, JD Director Office of Regulatory Policy, CDER Disclaimer:

More information

Recognized Pharmacopoeia in Registration system

Recognized Pharmacopoeia in Registration system Recognized Pharmacopoeia in Registration system Mrs. Prapassorn THANAPHOLLERT Acting Director, Bureau of Control Food and, THAILAND What is pharmacopoeia? Legal basis Outline Recognized Official Pharmacopoeia

More information

Caption: The equipment required for testing Fluticasone Propionate (FP) Inhalation Powder in line with a new product-specific monograph (USP36-NF31).

Caption: The equipment required for testing Fluticasone Propionate (FP) Inhalation Powder in line with a new product-specific monograph (USP36-NF31). Product-specific FDA guidance, and product-specific pharmacopeial monographs, point to the use of test equipment, some of which isn t included in the general USP/Ph. Eur. chapters for orally inhaled products

More information

Electronic Cigarettes and the Medical Society

Electronic Cigarettes and the Medical Society Electronic Cigarettes and the Medical Society Michele Coleman MPH, MPA 2014 WI Medical Society Health Policy Intern LRB 1844 Exempting electronic smoking devices from the types of smoking devices that

More information

European standard setting via CEN TC 437

European standard setting via CEN TC 437 European standard setting via CEN TC 437 Global forum on Nicotine 2015 CEN-CENELEC Alberto Simeoni Innovation Dept. GFN 2015 Warsaw, 5 June 2015 EUROPEAN STANDARDIZATION ORGANIZATIONS European Committee

More information

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium COMMENTS on a draft Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products Chemistry, Manufacturing, and Controls Documentation (Docket No. 99D-1454) Submitted by

More information

Responsible Practice in E-Vapour Products (EVP) Product Stewardship

Responsible Practice in E-Vapour Products (EVP) Product Stewardship Responsible Practice in E-Vapour Products (EVP) Product Stewardship Tanvir Walele, MSc, ERT 11 October 2016 1 Responsible Practice Responsible practice can be divided in to 3 areas: Pre-market product

More information

Cigarettes Determination of tobacco specific nitrosamines in mainstream cigarette smoke Method using LC-MS/MS

Cigarettes Determination of tobacco specific nitrosamines in mainstream cigarette smoke Method using LC-MS/MS INTERNATIONAL STANDARD ISO 19290 First edition 2016-12-01 Cigarettes Determination of tobacco specific nitrosamines in mainstream cigarette smoke Method using LC-MS/MS Cigarettes Dosage des nitrosamines

More information

FEATURES AND PERFORMANCE OF THE HPP SMOKING MACHINE. Dritan Xhillari

FEATURES AND PERFORMANCE OF THE HPP SMOKING MACHINE. Dritan Xhillari FEATURES AND PERFORMANCE OF THE HPP SMOKING MACHINE Dritan Xhillari Introduction The testing of tobacco burning cigarettes is governed by the testing methods set forth in ISO 3308 and the Canadian Intense

More information

Reports of advisory bodies

Reports of advisory bodies EXECUTIVE BOARD 142nd session 27 November 2017 Provisional agenda item 6.3 Reports of advisory bodies Expert committees and study groups 1 Report by the Director-General EVALUATION OF CERTAIN CONTAMINANTS

More information

ISO INTERNATIONAL STANDARD. Non-destructive testing Penetrant testing Part 1: General principles

ISO INTERNATIONAL STANDARD. Non-destructive testing Penetrant testing Part 1: General principles INTERNATIONAL STANDARD ISO 3452-1 First edition 2008-09-01 Non-destructive testing Penetrant testing Part 1: General principles Essais non destructifs Examen par ressuage Partie 1: Principes généraux Reference

More information

General concepts in the Ph. Eur.: theory and rationale

General concepts in the Ph. Eur.: theory and rationale General concepts in the Ph. Eur.: theory and rationale Cathie VIELLE Head of European Pharmacopoeia Department, EDQM / CoE 1 The structure of the Ph. Eur. General monographs Dosage form monographs General

More information

2015 Report 05 October 2015 Jeju, South Korea

2015 Report 05 October 2015 Jeju, South Korea Smoking Behaviour Sub-Group (TSB) 2015 Report 05 October 2015 Jeju, South Korea Smoking Behaviour Sub-Group Group originally set up as a committee reporting directly to the Scientific Commission, then

More information

ISO Process and Standards Under Development. ISO Principles

ISO Process and Standards Under Development. ISO Principles Inhalation & Nasal Drugs: The Regulatory Landscape ISO Process and Standards Under Development S.C. Nichols 7 1 ISO Principles ISO standards are developed according to the following principles: Consensus

More information

Regulatory Support for Tobacco Products. Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help.

Regulatory Support for Tobacco Products. Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help. Regulatory Support for Tobacco Products Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help. PREMARKET TOBACCO (PMTA) HUMAN FACTORS STUDIES SUBSTANTIAL EQUIVALENCE

More information

General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.

General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. General Chapter/Section: Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. of Commenters: 18 Editorial changes suggested by commenters have been reviewed by

More information

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS DISCUSSION IN THE SUBGROUP STABILITY April / May 2008 DISCUSSION

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 16 March 2006 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE? ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE? E-cigarettes have the potential to benefit adult smokers who are not pregnant if used as a complete substitute for regular cigarettes and other smoked tobacco

More information

Guideline for Advertising of e-cigarettes

Guideline for Advertising of e-cigarettes GUIDELINE 43 Guideline for Advertising of e-cigarettes Last Updated May 2015 What kind of product is this guideline for? What is the purpose of this guideline? Electronic, or e-cigarettes, are battery

More information

BRITISH PHARMACOPOEIA COMMISSION EXPERT ADVISORY GROUP: MEDICINAL CHEMICALS 3 SUMMARY MINUTES

BRITISH PHARMACOPOEIA COMMISSION EXPERT ADVISORY GROUP: MEDICINAL CHEMICALS 3 SUMMARY MINUTES BRITISH PHARMACOPOEIA COMMISSION EXPERT ADVISORY GROUP: MEDICINAL CHEMICALS 3 SUMMARY MINUTES A meeting of Expert Advisory Group (EAG): Medicinal Chemicals 3 (MC3) was held at 151 Buckingham Palace Road,

More information

Analytical method validation. Presented by Debbie Parker 4 July, 2016

Analytical method validation. Presented by Debbie Parker 4 July, 2016 Analytical method validation Presented by Debbie Parker 4 July, 2016 Introduction This session will cover: Guidance and references The types of test methods Validation requirements Summary Slide 2 PharmOut

More information

E-cigarette consumption and puffing topography data. Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015.

E-cigarette consumption and puffing topography data. Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015. E-cigarette consumption and puffing topography data Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015. Outline Nicoventures Introduction Topography and use patterns to inform

More information

E-Cigarettes: A Game Changer. Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences

E-Cigarettes: A Game Changer. Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences E-Cigarettes: A Game Changer Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences What is an e-cigarette? Battery Cartridge Indicator Light

More information

Meeting the Quality Challenge for Orally Inhaled Drug Products. Review Impact of Emerging EMA/MHRA Guidelines and Standards

Meeting the Quality Challenge for Orally Inhaled Drug Products. Review Impact of Emerging EMA/MHRA Guidelines and Standards IPAC-RS/RDD 2016 SYMPOSIUM Meeting the Quality Challenge for Orally Inhaled Drug Products Review Impact of Emerging EMA/MHRA Guidelines and Standards Joseph Lim (PhD) Senior Pharmaceutical Assessor (MHRA)

More information

Rationale for Establishing Tobacco Product Regulation

Rationale for Establishing Tobacco Product Regulation Rationale for Establishing Tobacco Product Regulation Erik Dybing, MD, PhD Conference of the Parties Technical Briefing Geneva, 7 February 2006 WHO Strategy for Tobacco Control Preventing uptake of tobacco

More information

DIRECTIVE 2014/40/UE AND TRANSPOSITION IN ITALY: LEGISLATIVE DECREE OF 12 JANUARY 2016, N. 6

DIRECTIVE 2014/40/UE AND TRANSPOSITION IN ITALY: LEGISLATIVE DECREE OF 12 JANUARY 2016, N. 6 DIRECTIVE 2014/40/UE AND TRANSPOSITION IN ITALY: LEGISLATIVE DECREE OF 12 JANUARY 2016, N. 6 The DIRECTIVE 2014/40 / EU (TPD: Tobacco Products Directive) of the European Parliament and of the Council of

More information

Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies.

Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies. LOS ANGELES CLINICAL TRIALS Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies. Ian M. Fearon, Alison Eldridge, Nathan Gale, Christopher J. Shepperd, Mike McEwan,

More information

The English experience in a European regulatory context. E-cigarette summit Washington DC 1 st May 2018 Deborah Arnott Chief Executive ASH (UK)

The English experience in a European regulatory context. E-cigarette summit Washington DC 1 st May 2018 Deborah Arnott Chief Executive ASH (UK) The English experience in a European regulatory context E-cigarette summit Washington DC 1 st May 2018 Deborah Arnott Chief Executive ASH (UK) Declaration of Interest ASH (UK) is a public health charity

More information

RISK FROM E-VAPOUR PRODUCTS FOR USERS AND BYSTANDERS

RISK FROM E-VAPOUR PRODUCTS FOR USERS AND BYSTANDERS RISK FROM E-VAPOUR PRODUCTS FOR USERS AND BYSTANDERS Dr Konstantinos Farsalinos Researcher Onassis Cardiac Surgery Center, Greece University of Patras, Greece COI Past 36 months 1 study funded by non-profit

More information

UK E-Cigarette Summit Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures

UK E-Cigarette Summit Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures UK E-Cigarette Summit 2017 Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures Ed Stephens University of St Andrews Scope of presentation

More information

The concept that not all tobacco and nicotine products

The concept that not all tobacco and nicotine products A Model Risk Continuum for Tobacco and Nicotine Products by Chris Proctor, Sudhanshu Patwardhan, and James Murphy The concept that not all tobacco and nicotine products present the same risks to human

More information

Towards a Smokefree Generation: A Tobacco Control Plan for England. Tim Baxter, Department of Health, England

Towards a Smokefree Generation: A Tobacco Control Plan for England. Tim Baxter, Department of Health, England Towards a Smokefree Generation: A Tobacco Control Plan for England 1 Tim Baxter, Department of Health, England Smoking rates are falling fast... 25 Adult Smoking prevalence in England (daily and non daily)

More information

E-Cigarette Aerosol Analysis Report

E-Cigarette Aerosol Analysis Report Report No. : TCT170329C001 Date : Apr. 12, 2017 Page No.: 1 of 6 Applicant: Address: ALD GROUP LIMITED ALD Building NO.2 Industrial 3rd Road, ShiXin Community, Shiyan Town, Bao An District, Shenzhen 518108,

More information

Guideline on quality of herbal medicinal products 2 /traditional herbal medicinal products

Guideline on quality of herbal medicinal products 2 /traditional herbal medicinal products 1 2 3 4 5 05 June 2018 EMA/HMPC/201116/2005 1 Rev. 3 Committee on Herbal Medicinal Products (HMPC) Guideline on quality of herbal medicinal products 2 /traditional herbal medicinal products DRAFT Revision

More information

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update FDLI s Enforcement, Litigation, and Compliance Conference Center for Tobacco Products Office of Compliance and Enforcement 2017 Update Ann Simoneau, Director Office of Compliance and Enforcement Center

More information

This document is a preview generated by EVS

This document is a preview generated by EVS TECHNICAL REPORT ISO/TR 19478-2 First edition 2015-08-01 ISO and Health Canada intense smoking parameters Part 2: Examination of factors contributing to variability in the routine measurement of TPM, water

More information

1st Annual Tobacco and Nicotine

1st Annual Tobacco and Nicotine #smokefree #vapefree #healthy me SAFE TOBACCO AND NICOTINE TASK FORCE PRESENTS. 1st Annual Tobacco and Nicotine Prevention Poster Contest CONTEST OVERVIEW: The 2016 smoking prevention poster contest is

More information

E-Cigarette Aerosol Analysis Report

E-Cigarette Aerosol Analysis Report Report No. : TCT171124C016 Date : Dec. 01, 2017 Page No.: 1 of 6 Applicant: Address: Shenzhen IJoy Technology Co., Ltd 3/F 13#Building,Hengmingzhu Tech. Industrial Park, Xiangxing Street, Shajing Town,

More information

Smoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017

Smoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017 Smoking, e-cigs and reduced risk products Dr John Schoonbee, IMS November 2017 2 The storyline smoking is bad yet many folks still smoke because quitting is very hard is it better, if one cannot quit,

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 21 September 2006 EMEA/CHMP/BWP/298390/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON

More information

E-Cigarette Aerosol Analysis Report

E-Cigarette Aerosol Analysis Report Report No. : TCT170822C007 Date : Aug. 28, 2017 Page No.: 1 of 6 Applicant: Address: Shenzhen IJoy Technology Co.,Ltd 3/F 13#Building, Hengmingzhu Tech. Industrial Park, Xiangxing Street, Shajing Town,

More information

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products 31 March 2011 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Committee on Herbal Medicinal Products (HMPC) Guideline on quality of herbal

More information

E-Cigarette Aerosol Analysis Report

E-Cigarette Aerosol Analysis Report Report No. : TCT180912C007 Date : Sep. 18, 2018 Page No.: 1 of 6 Applicant: Vandy Vape Address: 415, huafeng Internet + creative park, no.107 republic industrial road, xixiang, baoan district, shenzhen

More information

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re 2 Agenda Smoking is still a problem Stopping is hard Electronic cigarettes Reduced Risk tobacco products Males >15yr

More information

RE: Docket No. FDA-2014-N , Electronic Cigarettes and the Public Health

RE: Docket No. FDA-2014-N , Electronic Cigarettes and the Public Health VIA ELECTRONIC SUBMISSION June 30, 2015 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 RE: Docket No. FDA-2014-N-1936-0001, Electronic

More information

CORESTA Guide N o 18

CORESTA Guide N o 18 CORESTA Guide N o 18 November 2016 Technical Guide for Sample Handling and Sample Collection of E-Cigarettes and E-Vapour Generating Products E-Vapour Sub-Group 1. REVIEW AND HISTORY Issue Date Reason

More information

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007) November 2007 LIQUID PREPARATIONS FOR ORAL USE Final text for addition to The International Pharmacopoeia (November 2007) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications

More information

The Effect of Puff Profile and Volume on the Yields of E-Cigarettes

The Effect of Puff Profile and Volume on the Yields of E-Cigarettes The Effect of Puff Profile and Volume on the Yields of E-Cigarettes Dr M J Taylor, Filtrona Technology Centre Smoke Science/Product Technology Meeting Seville, Spain, 29 September to 03 October 2013 Introduction

More information

E-Cigarette Aerosol Analysis Report

E-Cigarette Aerosol Analysis Report Report No. : TCT180129C014-1 Date : Feb. 09, 2018 Page No.: 1 of 6 Applicant: Address: Shenzhen Smoant Technology Co., Ltd 5/F, Block 16, Changxing Science Park, Wan'an Road, Shayi Community, Shajing Town,

More information

2017_ST10_JinCathy.pdf. SSPT Document not peer-reviewed by CORESTA

2017_ST10_JinCathy.pdf. SSPT Document not peer-reviewed by CORESTA Investigation of TSNA Formation in Electronic Cigarette Liquids and Aerosols Xiaohong Cathy Jin, Karen C. Avery, Georgios D. Karles, William P. Gardner, Matt S. Melvin, Donna C. Smith, Willie J. Mckinney,

More information

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations 49th Annual Meeting Non-Sterile Compounding/ Sunil Jambhekar, B. Pharm., M.S., Ph.D Professor, Pharmaceutical Sciences LECOM Bradenton, School of Pharmacy Bradenton, FL 34211 Disclosure I do not have a

More information

Coventry Health Care of Georgia, Inc.

Coventry Health Care of Georgia, Inc. Coventry Health Care of Georgia, Inc. PRESCRIPTION DRUG RIDER (for High Deductible Health Plans) This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health Plan

More information

E-Cigarette Aerosol Analysis Report

E-Cigarette Aerosol Analysis Report Report No. : TCT180301C012 Date : Mar. 09, 2018 Page No.: 1 of 6 Applicant: Address: Shenzhen BYB Technology Co., Ltd. No. 1602, Honghai Bldg., Bldg. 8, Xingjijiayuan, Hongxing Community, Songgang St.,

More information

Effect of Sugars on Selected Toxicant Yields in e-cigarettes

Effect of Sugars on Selected Toxicant Yields in e-cigarettes CORESTA Congress, 11th October 2016, Berlin Effect of Sugars on Selected Toxicant Yields in e-cigarettes Jennifer Margham 1, Kevin McAdam 1 ST 31 BERLIN 2016 1 British American Tobacco, Group R&D, Southampton,

More information

UPDATE ON THE GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS

UPDATE ON THE GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS UPDATE ON THE GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS DDL2017 6-8 December 2017 Presented by Claudia Vincenzi on 7 December 2017 Quality Office EMA An agency of the European

More information

E-cigarettes: Evidence, perceptions and misconceptions. Martin Dockrell, Tobacco Control Programme Lead

E-cigarettes: Evidence, perceptions and misconceptions. Martin Dockrell, Tobacco Control Programme Lead E-cigarettes: Evidence, perceptions and misconceptions Martin Dockrell, Tobacco Control Programme Lead Smoking causes the greatest number of preventable deaths Are EC less tightly regulated in the UK than

More information

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j))

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j)) The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j)) January 12, 2011 Cristi Stark, MS Senior Regulatory Health Project Manager Office

More information

DECISION. Recalling further its decision FCTC/COP5(6) to adopt further partial guidelines;

DECISION. Recalling further its decision FCTC/COP5(6) to adopt further partial guidelines; 66 Conference of the Parties to the WHO Framework Convention on Tobacco Control Seventh session Delhi, India, 7 12 November 2016 12 November 2016 DECISION FCTC/COP7(14) Further development of the partial

More information

DEVELOPMENT OF A TECHNIQUE FOR THE DETERMINATION OF ph-values OF AEROSOLS GENERATED BY E-CIGARETTES

DEVELOPMENT OF A TECHNIQUE FOR THE DETERMINATION OF ph-values OF AEROSOLS GENERATED BY E-CIGARETTES DEVELOPMENT OF A TECHNIQUE FOR THE DETERMINATION OF ph-values OF AEROSOLS GENERATED BY E-CIGARETTES John H. Lauterbach, Ph.D., DABT Lauterbach & Associates, LLC Macon, GA 31210-4708 USA Outline for presentation

More information

The Role of EPAG in Standards and Regulatory Guidance Development

The Role of EPAG in Standards and Regulatory Guidance Development The Role of EPAG in Standards and Regulatory Guidance Development Jolyon P. Mitchell on behalf of EPAG Session 4: The Remit, Activities and Achievements of The European Pharmaceutical Aerosols Group 1

More information

The Latest on Vaping Among U.S. Teens

The Latest on Vaping Among U.S. Teens The Latest on Vaping Among U.S. Teens Jon Macy, PhD, MPH Indiana University School of Public Health Bloomington Presentation Outline Overview of Electronic Nicotine Delivery Systems (ENDS) New Prevalence

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS European Medicines Agency Inspections London, 16 February 2005 Doc Ref.: EMEA/CHMP/QWP/49313/2005 corr. COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF

More information

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use 25 October 1999 EMEA/HMPWP/23/99 EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS UPDATED DRAFT POINTS

More information

Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation

Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation Dr. Frauke Gaedcke, Waidesch Dr. Barbara Steinhoff, Konigswinter In collaboration with Dr. Helga Blasius,

More information

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products UNITED STATES REGULATION OF TOBACCO PRODUCTS Presented by Mitch Zeller Center Director FDA Center for Tobacco Products May 24, 2016 OVERVIEW OF TODAY S PRESENTATION Highlights of the Deeming Final Rule

More information

State Pharmacopoeia of Ukraine

State Pharmacopoeia of Ukraine State Pharmacopoeia of Ukraine WHO INTERNATIONAL MEETING OF WORLD PHARMACOPOEIAS 29.02 2.03 2012 Geneva, Executive Board Room Oleksandr Gryzodub Director of «Ukrainian Scientific Pharmacopoeial Center

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 01 September 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4

More information

Air Quality assessment during indoor use of the Tobacco Heating System 2.2

Air Quality assessment during indoor use of the Tobacco Heating System 2.2 Air Quality assessment during indoor use of the Tobacco Heating System 2.2 THS 2.2. is commercialized under the IQOS brand name Maya Mitova, Catherine Goujon Ginglinger, Michel Rotach, Serge Maeder Philip

More information

Family Smoking Prevention and Tobacco Control Act. Comments regarding crop protection agents

Family Smoking Prevention and Tobacco Control Act. Comments regarding crop protection agents Family Smoking Prevention and Tobacco Control Act (PUBLIC LAW 111-31 JUNE 22, 2009) Comments regarding crop protection agents Presentation Objectives What is the intent of FDA in regulating CPAs? What

More information

Updating the Malaria Vaccine Technology Roadmap

Updating the Malaria Vaccine Technology Roadmap Updating the Malaria Vaccine Technology Roadmap Vasee Moorthy MRCP PhD MPAC 14 March 2013 Purpose of this MPAC session MPAC to be updated on the strategic R&D framework for malaria vaccines, including

More information

Understanding Regulatory Global Requirements for Nasal Drug Products. Julie D. Suman, Ph.D. April 8, 2016

Understanding Regulatory Global Requirements for Nasal Drug Products. Julie D. Suman, Ph.D. April 8, 2016 Understanding Regulatory Global Requirements for Nasal Drug Products Julie D. Suman, Ph.D. April 8, 2016 AGENDA NDA vs ANDA Regulatory Approaches for Bioequivalence (BE) FDA Drug Specific Guidances FDA,

More information

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS) Association of South East Asian Nations (ASEAN) ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS) Version 3.0 CONTENTS 1. Introduction...2 2. Objective...

More information

Harmful and potentially harmful constituents in e-cigarettes

Harmful and potentially harmful constituents in e-cigarettes Harmful and potentially harmful constituents in e-cigarettes Prof. Riccardo Polosa Institute of Internal Medicine Centre for the Prevention and Cure of Tabagism University of Catania - ITALY Global Forum

More information

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) POINTS TO CONSIDER ON THE JUSTIFICATION OF HOMEOPATHIC USE

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) POINTS TO CONSIDER ON THE JUSTIFICATION OF HOMEOPATHIC USE HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) POINTS TO CONSIDER ON THE JUSTIFICATION OF HOMEOPATHIC USE DISCUSSION IN THE SUBGROUP March-April 2009 DISCUSSION IN THE HMPWG 30 April 2009 ADOPTION

More information

Proposed Deeming Regulations: What s the Path Forward?

Proposed Deeming Regulations: What s the Path Forward? Proposed Deeming Regulations: What s the Path Forward? Gal Cohen, Ph.D. Head of Scientific and Regulatory Affairs Ploom, Inc. James & Adam Vision and mission Vaporization technology company Obsolete combustion

More information

Key Variables in Assessing ENDS Devices AND WHY THAT ISN T VOLTS

Key Variables in Assessing ENDS Devices AND WHY THAT ISN T VOLTS Key Variables in Assessing ENDS Devices AND WHY THAT ISN T VOLTS About Evolv and John Bellinger Evolv is the largest domestic manufacturer of ENDS control circuitry Founded 2010, located in Hudson, OH

More information

Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21

Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21 Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21 st October 2015 Contents Evolution of products across

More information

Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture

Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture 11 July 2011 EMA/CHMP/BWP/368186/2011 Committee for Human Medicinal Products (CHMP) Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in Draft Agreed by Biologics Working

More information

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15 00:00 British American Tobacco 00:02 00:03 The Electronic Cigarette 00:07 00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15 00:15 Our

More information